Regression of cardiovascular remodeling in hypertension: Novel relevant mechanisms

Figure 2 Comparative levels of Rho kinase activity in circulating leukocytes (determined as phosphorylated/total MYPT-1 ratio) in healthy normotensive controls, in untreated hypertensive patients without LVH and in untreated hypertensive patients with left ventricular hypertrophy (Data shown as mean ± SEM). ^aP < 0.01 vs Controls; ^bP < 0.01 vs untreated hypertensive patients without left ventricular hypertrophy (after significant ANOVA, respectively). Adapted, with permission from reference[47]. LVH: Left ventricular hypertrophy.